Stay updated on Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Sign up to get notified when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 on the site. This represents a minor platform update with no changes to the study details or on-page content.
    Difference
    0.0%
    Check dated 2026-08-08T23:20:18.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page version was updated from v3.6.3 to v3.6.4. This appears to be a maintenance update with minor fixes that do not change the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T16:56:39.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3 on the page, signaling a new version of the site's content or template. This is an internal update and does not alter the study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-07-04T04:27:57.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, signaling a new site/documentation release. This reflects backend/versioning updates rather than changes to study details or user-facing features.
    Difference
    0.0%
    Check dated 2026-06-27T02:48:22.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Enrollment is closed as indicated by the new status. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling and revision version to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:50:41.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The page now shows the updated revision indicator v3.5.5, replacing the previous v3.5.4, indicating a new build of the page.
    Difference
    0.0%
    Check dated 2026-06-05T09:58:26.000Z thumbnail image

Stay in the know with updates to Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Letetresgene Autoleucel+Pembrolizumab in NY-ESO-1+ MM Clinical Trial page.